Renalytix Plc (RNLXY)
OTCMKTS
· Delayed Price · Currency is USD
0.2400
+0.0350 (17.07%)
Apr 28, 2025, 4:00 PM EDT
Renalytix Revenue
Renalytix had revenue of $1.25M in the quarter ending December 31, 2024, with 76.45% growth. This brings the company's revenue in the last twelve months to $2.89M, up 20.08% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
2.89M
Revenue Growth
+20.08%
P/S Ratio
12.26
Revenue / Employee
28.37K
Employees
102
Market Cap
35.47M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Renalytix News
- 5 weeks ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire